Theralase Technologies Inc. (CVE:TLT)

PRESS RELEASE

published on 10/05/2023 at 13:00, 2 years 3 months ago

Theralase(R) Files US Patent for Enhanced Immunotherapy
PRESS RELEASE

published on 09/29/2023 at 13:00, 2 years 4 months ago

Theralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)
PRESS RELEASE

published on 09/27/2023 at 13:00, 2 years 4 months ago

Theralase(R) Successfully Completes Non-GLP Toxicity Analysis for Brain Cancer
PRESS RELEASE

published on 09/21/2023 at 22:35, 2 years 4 months ago

Theralase(R) Grants Stock Options
PRESS RELEASE

published on 09/07/2023 at 10:30, 2 years 4 months ago

Theralase(R) Closes Private Placement Equity Financing
PRESS RELEASE

published on 08/29/2023 at 22:30, 2 years 5 months ago

Theralase Release’s 2Q2023 Interim Financial Statements
PRESS RELEASE

published on 06/30/2023 at 22:35, 2 years 7 months ago

Theralase(R) Closes Non-Brokered Private Placement Equity Financing
PRESS RELEASE

published on 06/06/2023 at 13:00, 2 years 7 months ago

Theralase(R) Announces Appointment of New Independent Director
PRESS RELEASE

published on 05/31/2023 at 03:30, 2 years 8 months ago

Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements
PRESS RELEASE

published on 05/31/2023 at 01:35, 2 years 8 months ago

Theralase(R) Releases 1Q2023 Interim Financial Statements

Published on 01/31/2026 at 03:15, 1 day 15 hours ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 1 day 16 hours ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 1 day 16 hours ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 1 day 18 hours ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 1 day 19 hours ago

Avidian Gold Corp. Announces Director Resignation

News